Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
08/2010
08/17/2010US7776535 making a fluorinated protein using orthogonal tRNA that recognizes selector codon, a fluorinated aromatic amino acid and an orthogonal aminoacyl-tRNA synthetase; translation, aminoacylation
08/17/2010US7776534 Episomal fusion gene
08/17/2010US7776533 used in binding and detecting immobilized and solubilized phosphorylated target molecules, isolation of phosphorylated target molecules from a complex mixture and aiding in proteomic analysis wherein kinase and phosphatase substrates and enzymes can be identified
08/17/2010US7776532 Method for in vitro recombination
08/17/2010US7776531 Compositions and methods for stabilizing surface bound probes
08/17/2010US7776530 sample is provided on or applied onto a solid matrix and the subsequent amplification and detection steps are performed in one single, sealed reaction vial without removing the matrix; minimized risks related to contamination due to minimal handling of the samples
08/17/2010US7776529 For fluorescent detection/quantitation of DNA; kits; staining solutions
08/17/2010US7776528 Radiative decay engineering
08/17/2010US7776527 identifying a test agent as reducing apoptosis of a macrophage cell; reducing the activity of Protein Kinase R
08/17/2010US7776526 conatacting an extracellular haemoglobin sample from annelids with dissociating agent e.g. a mixture containing dithiothreitol (DTT) or tris(2-carboxyethyl)phosphine (TCEP) hydrochloride or beta-mercaptoethanol and a dissociation buffer for a sufficient length of time in order to separate the chains
08/17/2010US7776525 Method of diagnosing disease relating to endometriosis
08/17/2010US7776524 Detecting the presence of nucleic acid sequence variants in a subpopulation of nucleic acid molecules in a biological sample ; useful for identifying individuals with mutations indicative of cancer
08/17/2010US7776523 assaying a sample comprising prostate cells, an RNA comprising a Gag or Pol encoding sequence of a human endogenous mouse mammary tumor virus (MMTV)-like subgroup 2 (HML-2) retrovirus, HERV-K (CH)
08/17/2010US7776522 by generating mass profile data for a biological sample from the subject and correlating the mass profile data with reference mass profiles to detect the presence or absence, and/or quantity of at least one biomarker associated with HPV infection
08/17/2010US7776521 detecting a severe acute respiratory syndrome-associated coronavirus (SARS-CoV); amplification
08/17/2010US7776520 Use of microphthalmia for diagnosis, prognosis and/or treatment of melanoma
08/17/2010US7776519 detection of mesenchymal tumoral cells by using the Slug (zinc fingers domains) gene; biomarker
08/17/2010US7776518 Detection of survivin in the biological fluids of cancer patients
08/17/2010US7776361 NELL-1 enhanced bone mineralization
08/17/2010US7776340 has a low level of homology to the enteric canine coronavirus, but which has a high level of homology to all bovine coronavirus strains (eg Quebec and LY138) and human coronavirus strain OC43
08/17/2010US7776335 Microorganismal enzymatic polypeptide for use in developing vaccine for prevention and treatment of nesserial infection
08/17/2010US7776266 Portable testing device for use by consumers to detect the presence of harmful contaminants in foodstuff to avoid consumption of contaminated food; includes a vessel adapted for holding a liquefied food sample, a liquefier, test assay dispensable from the device; rapid real-time testing; portable, simple
08/17/2010US7776193 Cell electrophysiological sensor
08/17/2010US7775368 the nucleic acid molecule elongated and fixed onto a planar surface so that the nucleic acid molecule remains accessible for enzymatic reactions and/or hybridization reactions
08/17/2010CA2559299C Probes for detecting protein nuclear transport and method for detecting and quantifying protein nuclear transport using the same
08/17/2010CA2525413C Compositions, methods and kits for determining the presence of trichomonas vaginalis in a test sample
08/17/2010CA2487048C Method for solution based diagnosis
08/17/2010CA2481535C Use of ep4 receptor ligands in the treatment of il-6 involved diseases
08/17/2010CA2440424C Novel protein isolated from pleurotus cornucopiae
08/17/2010CA2411436C A method for detecting protein inhibitors and ligands
08/17/2010CA2389036C Antisense modulation of integrin-linked kinase expression
08/17/2010CA2357804C Method and polynucleotides for determining translational efficiency of a codon
08/17/2010CA2344055C Method for fractional determination of cholesterol in lipoproteins and a reagent therefor
08/17/2010CA2269634C Reagents and methods useful for detecting diseases of the breast
08/17/2010CA2233455C Method and apparatus for detecting microbiological fouling in aqueous systems
08/17/2010CA2182905C Method for ordering macromolecules by means of a moving meniscus, and uses thereof
08/17/2010CA2144527C Up-converting reporters for biological and other assays using laser excitation techniques
08/12/2010WO2010091406A2 Improvements in and relating to devices
08/12/2010WO2010091400A2 Improvements in and relating to analysis
08/12/2010WO2010091354A2 Akt tyrosine 176 phosphorylation cancer biomarker
08/12/2010WO2010091328A1 Diagnostic and therapeutic uses of gnptab, gnptg, and nagpa in stuttering
08/12/2010WO2010091290A1 Determination of the liver toxicity of an agent
08/12/2010WO2010091233A1 Diagnosis and prognosis of renal injury and renal failure
08/12/2010WO2010091231A1 Methods and compositions for diagnosis and prognosis of renal injury and renal failure
08/12/2010WO2010091204A1 Dual targeting of mir-208 and mir-499 in the treatment of cardiac disorders
08/12/2010WO2010091134A1 GALECTIN-3 nsSNP MARKER FOR CANCER
08/12/2010WO2010091060A1 Generation of random double strand breaks in dna using enzymes
08/12/2010WO2010091049A2 Diagnosis and treatment of cancer
08/12/2010WO2010091046A2 Systems and methods for high throughput, high fidelity, single molecule nucleic acid sequencing using time multiplexed excitation
08/12/2010WO2010091041A1 Cell based assays for the triglyceride synthesis pathway
08/12/2010WO2010090857A2 Methods for amplifying hepatitis c virus nucleic acids
08/12/2010WO2010090848A2 Apparatus and method to characterize blood and red blood cells via erythrocyte membrane fragility quantification
08/12/2010WO2010090834A2 Netrin-1 as a biomarker of injury and disease
08/12/2010WO2010090471A2 Novel diagnostic marker for type 1 diabetes mellitus
08/12/2010WO2010090319A1 Coelenterazine analogs and manufacturing method thereof
08/12/2010WO2010090285A1 Screening method for therapeutic agent for epilepsy
08/12/2010WO2010090265A1 Fluorescent solvatochromic pigment
08/12/2010WO2010090030A1 Blank sample
08/12/2010WO2010089707A1 Methods and kits for determining sensitivity or resistance of prostate cancer to radiation therapy
08/12/2010WO2010089569A1 Rapid detection of bacteria using mass spectrometric analysis
08/12/2010WO2010089550A1 Assay products, devices and method
08/12/2010WO2010089547A1 Assay products, devices and method (vre)
08/12/2010WO2010089541A1 Assay products, devices and method (klebsiella)
08/12/2010WO2010089538A2 Methods of detecting colorectal cancer
08/12/2010WO2010089470A1 Thermal validation apparatus, assembly including a device for the thermal processing of biological samples and such an apparatus, and method for manufacturing such an apparatus
08/12/2010WO2010089374A1 Xanthomonas campestris pv. campestris resistant brassica plant and preparation thereof
08/12/2010WO2010088775A1 Methods and uses of hypoxic compartment cells
08/12/2010WO2010088761A1 Method and apparatus for manipulating and detecting analytes
08/12/2010WO2010070637A3 Method for distinguishing between adrenal tumors
08/12/2010WO2010067307A3 In vitro methods and compositions for the diagnosis and/or treatment of adenocarcinoma
08/12/2010WO2010063818A3 Methods for selecting protease resistant polypeptides
08/12/2010WO2010060996A3 Prediction of lipid-metabotype-related physiological susceptibilities
08/12/2010WO2010059981A3 High complexity mammalian display library and methods of screening
08/12/2010WO2010058393A3 Compositions and methods for the prognosis of colon cancer
08/12/2010WO2010044932A3 Nanofluidic channels with integrated charge sensors and methods based thereon
08/12/2010WO2010040108A3 Method for measuring carbon nanotubes taken-up by a plurality of living cells
08/12/2010WO2010033371A3 Molecular markers for lung and colorectal carcinomas
08/12/2010WO2010029170A3 Method for the prognosis and diagnosis of type ii diabetes in critical persons
08/12/2010WO2009085234A9 Use of micro-rna as a biomarker of immunomodulatory drug activity
08/12/2010WO2009069001A3 Stratifin directed diagnostics for neoplastic disease
08/12/2010WO2006008575A9 Construction of a comparative database and identificaiton of virulence factors through comparison of polymorphic regions in clinical isolates of infectious organisms
08/12/2010US20100205696 Novel herbicide resistance gene
08/12/2010US20100205695 Promoters for regulation of gene expression in plant roots
08/12/2010US20100205693 Promoters for regulation of gene expression in plant roots
08/12/2010US20100205690 Plants With Increased Yield
08/12/2010US20100205684 Chicken embryonic stem cell and method for evaluation thereof
08/12/2010US20100204559 Device and method for determining analyte levels
08/12/2010US20100204555 Device and method for determining analyte levels
08/12/2010US20100204554 Electrochemical Analyte Sensor
08/12/2010US20100204324 Optically Active N-(Alpha-Mercaptopropionyl)Glycine
08/12/2010US20100204322 Method of treating autoimmune diseases
08/12/2010US20100204311 Normal-tension glaucoma model and method for evaluation of test substances by using same
08/12/2010US20100204309 Oligonucleotide compositions for the treatment of alzheimer's disease
08/12/2010US20100204299 C-cbl and antagonists thereof for the treatment and diagnosis of cancer
08/12/2010US20100204266 Compositions for use in identification of mixed populations of bioagents
08/12/2010US20100204253 Ribosome Structure and Protein Synthesis Inhibitors
08/12/2010US20100204251 Molecular target of neurotoxicity
08/12/2010US20100204208 Protein kinase c inhibitors and uses thereof
08/12/2010US20100204184 Phosphonates useful as modulators of T-gamma-9-delta-2 activity
08/12/2010US20100204182 Ectonucleotidase inhibitors